Dawonmedax Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas (NCT05737212) | Dawonmedax Co., Ltd. | 2022-12-05 |
Track Dawonmedax Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.